Author Correction: African-centric TP53 variant increases iron accumulation and bacterial pathogenesis but improves response to malaria toxin

Nat Commun. 2020 Mar 19;11(1):1541. doi: 10.1038/s41467-020-15366-x.

¹ Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, PA, 19104, USA.
² Department of Genetics, The Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104, USA.
³ Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, PA, 19104, USA.
⁴ Graduate Group in Biochemistry and Molecular Biophysics, The Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104, USA.
⁵ Program in Immunology, Microenvironment and Metastasis, The Wistar Institute, Philadelphia, PA, 19104, USA.
⁶ Southern Iron Disorders Center, Birmingham AL 35209 USA and Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
⁷ Bioinformatics Facility, The Wistar Institute, Philadelphia, PA, 19104, USA.
⁸ Department of Genetics, The Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104, USA. georged@pennmedicine.upenn.edu.
⁹ Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, PA, 19104, USA. mmurphy@wistar.org.
¹⁰ Vaccine and Immunotherapy Center, The Wistar Institute, Philadelphia, PA, 19104, USA. fdotiwala@wistar.org.

^# Contributed equally.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.